Alendronate inhibits periprosthetic bone loss around uncemented femoral components. (Q50698033)

17 March 2018

title

Alendronate inhibits periprosthetic bone loss around uncemented femoral components. (English)

1 reference

17 March 2018

author name string

Takashi Nishioka

1

1 reference

17 March 2018

Shoji Yagi

2

1 reference

17 March 2018

Tadashi Mitsuhashi

3

1 reference

17 March 2018

Masafumi Miyamoto

4

1 reference

17 March 2018

Tatsuya Tamura

5

1 reference

17 March 2018

Toru Kobayashi

6

1 reference

17 March 2018

Tetsuya Enishi

7

1 reference

17 March 2018

publication date

20 April 2007

1 reference

17 March 2018

Journal of Bone and Mineral Metabolism

published in

1 reference

17 March 2018

volume

25

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

179-183

1 reference

17 March 2018

https://scigraph.springernature.com/pub.10.1007/s00774-006-0743-7

exact match

0 references

cites work

Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00774-006-0743-7

Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry--a 3-year follow-up study

21 January 2018

1 reference

12 December 2020

Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem

1 reference

12 December 2020

Quantifying bone loss from the proximal femur after total hip arthroplasty

1 reference

12 December 2020

"Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening

1 reference

12 December 2020

Longitudinal evaluation of time related bone remodeling after cementless total hip arthroplasty

1 reference

12 December 2020

Experimental studies of bone remodeling in total hip arthroplasty

1 reference

12 December 2020

Functional adaptation and ingrowth of bone vary as a function of hip implant stiffness

1 reference

12 December 2020

Bone density at the proximal femur after total hip arthroplasty

1 reference

12 December 2020

Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models

1 reference

12 December 2020

Maintenance of proximal bone mass with an uncemented femoral stem analysis with dual-energy x-ray absorptiometry

1 reference

12 December 2020

Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study.

1 reference

12 December 2020

Determinants of stress shielding: design versus materials versus interface

1 reference

12 December 2020

Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases

1 reference

12 December 2020

Dual-energy X-ray absorptiometry measurement of bone mineral density around porous-coated cementless femoral implants. Methods and preliminary results

1 reference

12 December 2020

Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty

1 reference

12 December 2020

Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study

1 reference

12 December 2020

A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group

1 reference

12 December 2020

Temporal changes of periprosthetic bone density in patients with a modular noncemented femoral prosthesis

1 reference

12 December 2020

A prospective study of proximal femur bone mass following cemented and uncemented hip arthroplasty

1 reference

12 December 2020

Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study

1 reference

12 December 2020

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones

1 reference

12 December 2020

A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group.

1 reference

12 December 2020

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women

1 reference

12 December 2020

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

12 December 2020

The effect of stem stiffness on femoral bone resorption after canine porous-coated total hip arthroplasty

1 reference

12 December 2020

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

12 December 2020

10.1007/S00774-006-0743-7

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

17447116

1 reference

17 March 2018